GLOBAL STEM CELLS GROUP TO ATTEND TISSUE ENGINEERING & REGENERATIVE MEDICINE CONFERENCE | Stem Cells Course

GLOBAL STEM CELLS GROUP TO ATTEND TISSUE ENGINEERING & REGENERATIVE MEDICINE CONFERENCE

For Immediate Release: June 25, 2017
Contact: Mr Benito Novas
info@stemcellsgroup.com
Phone: + 1 305 560 5337

GLOBAL STEM CELLS GROUP TO ATTEND TISSUE ENGINEERING & REGENERATIVE MEDICINE CONFERENCE THIS OCTOBER
International Society of Stem Cells Applications to promote their Fellowship in Cell Therapy and Tissue Engineering Course during the event.

Barcelona, Spain – Global Stem Cells Group, an international network of regenerative medicine professionals, practitioners, researchers, and teachers, this week announced they will be attending the 7th International Conference on Tissue Engineering & Regenerative Medicine with a special focus on transforming repairs into regeneration this October 2 to the 4th in Barcelona, Spain.

To bring together world-class personalities working on stem cells, tissue engineering and regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair, the conference will present Global Stem Cells Group with a formidable international platform for connecting with leading regenerative medicine personnel in action today.

“We are constantly looking for ways to collaborate with other like-minded, passionate individuals all looking to better the study of regenerative medicine,” said Dr. Benito Novas, Founder and Owner of Global Stem Cells Group. “We are honored to be attending this year’s conference in Barcelona, Spain, and look forward to hosting our Fellowship program starting on September 4, 2017.”

The Fellowship in Cell Therapy and Tissue Engineering Course is a 6-day workshop that results in a certificate of completion issue by the President of Westminster Graduate School and Global Stem Cells Group. During the course, students will be immersed in a detailed program that focuses on hands-on experience in stem cell characterization and laboratory applications. Patients learn cell culture including plating, trypsinization, harvesting, and cryopreservation. At the end, students have an understanding of control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma, and sterility.

Since the course focuses on immersive experience, patients are able to witness the procedures in real-time with professional support the entire time.

“We understand that the nature of our industry requires real, immersive, and professionally monitored exposure that prepares the students for expert application of stem cells once they complete our courses,” said Dr. Novas. “Spread the word on the availability of our Fellowship in Cell Therapy offering, and head on over to our ISSCA affiliate platform to learn more about the course offerings.”

The next Fellowship will take place from September 4 to the 9 in Bucheon-Si Gyeong-GI Province in the Republic of Korea.